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Abstract
Previously we structurally characterized five glucosylated lactose derivatives (F1–F5) with a degree of polymerization (DP) of 3–
4 (GL34), products of Lactobacillus reuteri glucansucrases, with lactose and sucrose as substrates. Here, we show that these
GL34 compounds are largely resistant to the hydrolytic activities of common carbohydrate-degrading enzymes. Also, the ability
of single strains of gut bacteria, bifidobacteria, lactobacilli, and commensal bacteria, to ferment the GL34 compounds was
studied. Bifidobacteria clearly grew better on the GL34 mixture than lactobacilli and commensal bacteria. Lactobacilli and the
commensal bacteria Escherichia coliNissle and Bacteroides thetaiotaomicron only degraded the F2 compound α-D-Glcp-(1→
2)-[β-D-Galp-(1→ 4)-]D-Glcp, constituting around 30% w/w of GL34. Bifidobacteria digested more than one compound from
the GL34mixture, varying with the specific strain tested. Bifidobacterium adolescentiswas most effective, completely degrading
four of the five GL34 compounds, leaving only one minor constituent. GL34 thus represents a novel oligosaccharide mixture
with (potential) synbiotic properties towards B. adolescentis, synthesized from cheap and abundantly available lactose and
sucrose.
Keywords Glucosylated lactose derivatives (GL34) . Synbiotics . Bifidobacterium . Lactobacillus . Probiotic bacteria
Introduction
The human gut microflora has drawn increasing attention in
recent years. It constitutes a very interesting ecosystem that
varies in density and functionality in the different gut com-
partments (Ley et al. 2006). These complex ecosystems have a
significant impact on host well-being (Flint et al. 2007).
Strongest interest is focused on understanding what factors
cause variations in microbiota composition and how these
gut bacteria modulate host health (Louis et al. 2007). Our
work aims to stimulate the growth of health-promoting probi-
otic gut bacteria by using newly synthesized non-digestible
carbohydrates, i.e., prebiotic compounds.
According to the latest definition, a prebiotic is Ba substrate
that is selectively utilized by host microorganisms conferring a
health benefit^ (Gibson et al. 2017). Recently, part of the def-
inition was disputed, since selective stimulation of health-
promoting species seems not exclusively necessary to confer
health benefits (Bindels et al. 2015; Yan et al. 2018). Generally,
prebiotics are carbohydrates that are not fully digested by the
host. They are fermented by various commensal and health-
beneficial gut bacteria, thus promoting their growth and activity
which may confer health benefits upon the host (Roberfroid
et al. 2010; Callaway et al. 2008). To date, the most well-
known prebiotics, supported by good quality data, are human
milk oligosaccharides (hMOS) (Bode 2012), β-galacto-
oligosaccharides (GOS), β-fructo-oligosaccharides (FOS), inu-
lin, and lactulose (Slavin 2013; Macfarlane et al. 2008). All of
these prebiotics are also hydrolyzed by brush border enzymes,
but not completely (Ferreira-Lazarte et al. 2017). Isomalto-/
malto-polysaccharides (IMMP) (Bai et al. 2016; Rycroft et al.
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00253-018-9473-8) contains supplementary
material, which is available to authorized users.
* Lubbert Dijkhuizen
L.Dijkhuizen@rug.nl
1 Microbial Physiology, Groningen Biomolecular Sciences and
Biotechnology Institute (GBB), University of Groningen,
Nijenborgh 7, 9747 AG Groningen, The Netherlands
2 Present address: CarbExplore Research B.V, Zernikepark 12, 9747
AN Groningen, The Netherlands
3 Present address: Department of Laboratory Medicine, University
Medical Center Groningen, University of Groningen, 9713
GZ Groningen, The Netherlands
Applied Microbiology and Biotechnology (2019) 103:707–718
https://doi.org/10.1007/s00253-018-9473-8
2001), xylo-oligosaccharides (XOS) (Marquina et al. 2002),
resistant starch (Lehmann and Robin 2007), and soy oligosac-
charides also are (emerging) prebiotic oligosaccharides (Jaskari
et al. 1998), althoughmore data about their effects on gut health
are still needed. Each of these prebiotic compounds may exert
specific and selective effects on gut bacteria. The search for new
and effective prebiotics combined with specific probiotics
(synbiotics) is increasing rapidly (Pandey et al. 2015; Rastall
and Maitin 2002).
Lactose-derived oligosaccharides attract much attention in
view of their prebiotic potential. One example is GOS, which
are synthesized from lactose by enzymatic trans-galactosylation
using β-galactosidases, achieving a degree of polymerization be-
tween 3 and 10 (Van Leeuwen et al. 2016). This prebiotic has
been widely studied and shown to stimulate probiotic bacteria to
various extents (Macfarlane et al. 2008; Boehm and Moro 2008;
Rijnierse et al. 2011). Another commercially available prebiotic in
this group is lactosucrose, which is hardly utilized by human
digestive enzymes and has stimulatory effects on both lactobacilli
and bifidobacteria (Ohkusa et al. 1995; García-Cayuela et al.
2014). Also, the selective bifidogenic effect of 4′-galactosyl-
kojibiose, corresponding to compound F2 in our GL34 mixture
(Pham et al. 2017), on Bifidobacterium breve 26M2 has been
reported (García-Cayuela et al. 2014). These results indicate that
there are clear perspectives to further develop and expand this
group of lactose-derived prebiotic oligosaccharides.
We recently reported synthesis of a mixture of five novel
lactose-derived oligosaccharides (F1–F5) using the
Lactobacillus reuteri glucansucrase enzymes Gtf180-ΔN and
GtfA-ΔN (Pham et al. 2017). Their structural characterization
revealed the presence of various glycosidic linkages, α(1→ 2/3/
4), withDP of 3 and 4 (Pham et al. 2017) (Scheme 1). Four out of
these five structures were new and only F2 4′-galactosyl-
kojibiose had been reported before. In this work, their resistance
to degradation by common carbohydrate-degrading enzymes
was studied by in vitro incubations. Also, the growth of pure
cultures of common gut bacteria, including commensal and pro-
biotic strains, on these novel compounds was evaluated and
compared with well-known prebiotic mixtures (GOS and
FOS). The GL34 mixture particularly stimulated growth of
Bifidobacterium adolescentis. This is also of interest from an
industrial perspective, since these new oligosaccharides with
very specific prebiotic effects are produced from low-cost lactose
and sucrose and may be an option for developing synbiotics.
Materials and methods
Bacterial strains, chemicals, and reagents
Bacteroides thetaiotaomicron VPI-5482, Lactobacillus
acidophilus ATCC 4356, B. adolescentis ATCC 15703, and
Bifidobacterium longum subsp. infantis ATCC 15697 were
purchased from ATCC. B. breve DSM 20213 was obtained
from the DSMZ culture collection. L. reuteri strain 121 was
obtained from TNO Quality of Life, Zeist, the Netherlands.
Lactobacillus casei W56 was provided by Winclove
Probiotics B.V. (Amsterdam). All reagents, chemicals, or me-
dium components were purchased from Sigma (Zwijndrecht,
Netherlands), or as stated otherwise. The purifiedGOSmixture
TS0903 (lacking glucose, galactose, and lactose) was provided
by FrieslandCampina Domo; its detailed GOS composition was
published elsewhere (Lammerts van Bueren et al. 2017). The
GOS/FOS mixture used is a 90:10 (w/w) mixture of the purified
TS0903 GOS and long-chain Inulin (lc-Inulin, Frutafit TEX,
provided by SENSUS, Roosendaal, TheNetherlands), also serv-
ing as a control for the current prebiotic formula added to infant
nutrition (Boehm and Moro 2008).
Lactobacillus growth experiments
Lactobacilli were pre-cultured in MRS medium (Oxoid,
Basingstoke, UK) anaerobically (or by using theGasPak system
(Becton, Dickinson and Company, Sparks, USA)) under an N2
atmosphere for up to 2 days at 37 °C (Daniels and Zeikus 1975).
Then, 1-mL samples of the pre-cultures were harvested by cen-
trifugation (2500×g, 2 min). The bacterial pellets were washed
twice with sterile 10% NaCl and diluted 25-fold in 2× modified
MRS (mMRS; medium that does not contain a carbon source
for Lactobacilli) (Watson et al. 2013). In separate tubes, carbo-
hydrates were dissolved with Milli-Q water to 10 mg mL−1 and
sterilized by filtration using 0.2-μm cellulose acetate filters (the
GL34 mixture) or by autoclaving solutions (glucose). Cultures
were inoculated by mixing 1:1 diluted bacterial suspensions
with sterilized carbohydrate solutions in sterile microtiter plates
to obtain an initial OD600 of 0.01. Inoculation of microtiter
plates was carried out in an anaerobic glove box (Sicco,
Grünsfeld, Germany) with a constant nitrogen flow, the micro-
titer plates sealed air tightly and transferred into a plate reader
placed under constant N2 flow. Glucose was used as positive
control to compare growth of these lactobacilli on themixture of
GL34 compounds. Media without an added carbon source was
used as negative control. Bacterial growth was followed at
37 °C by measuring the optical density at 600 nm (OD600 nm)
in 5-min intervals. OD values of the negative control samples
(no carbohydrate added) were deducted while measuring their
corresponding samples and positive controls.
Bifidobacterium and B. thetaiotaomicron growth
experiments
The Bifidobacterium strains were sub-cultured (from stocks
stored at − 80 °C) in 10 mL of Bifidobacterium medium (BM)
supplemented with 1% glucose (1-L BM contained 10 g
trypticase peptone, 2.5 g yeast extract, 3 g tryptose, 3 g
K2HPO4, 3 g KH2PO4, 2 g triammonium citrate, 0.3 g pyruvic
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acid, 1 mL Tween 80, 0.574 g MgSO4·7H2O, 0.12 g MnSO4·
H2O, and 0.034 g FeSO4·7H2O). After autoclaving, BM was
supplemented with 0.05% (w/v) filter-sterilized cysteine-HCl
(Ryan et al. 2006). B. thetaiotaomicron was cultured using a
carbon-limited minimally defined medium of 100 mM KH2PO4
(pH 7.2), 15 mM NaCl, 8.5 mM (NH4)2SO4, 4 mM L-cysteine,
1.9 M hematin, 200 M L-histidine, 100 nM MgCl2, 1.4 nM
FeSO4·7 H2O, 50 M CaCl2, 1 g mL
−1 vitamin K3, 5 ng mL
−1
vitamin B12, and individual carbon sources (0.5%, w/v)
(Koropatkin et al. 2008). Carbohydrates were prepared by dis-
solving inMilli-Qwater to 10mgmL−1 and sterilized by filtration
using 0.2-μm cellulose acetate filters (the GL34 mixture, GOS,
FOS) or by autoclaving solutions (lactose). Growth was carried
out in fermentation tubes at 37 °C under anaerobic conditions
maintained by GasPak EZ anaerobe container system (BD,
New Jersey,USA). Cell suspensions fromovernight cultureswere
prepared in 3 mL of BM supplemented with different carbon
source in a final concentration of 5 mg mL−1. BM without an
added carbon source was used as negative control. OD600 nm
measurements of the fermentation tubes were carried out manu-
ally at 1-h intervals and data used to generate growth curves. OD
values of the negative control samples (no carbohydrate added)
were deducted while measuring their corresponding samples and
positive controls.
Escherichia coli Nissle growth experiments
Escherichia coli Nissle was cultured using M9 medium as
previously described, at 37 °C under aerobic conditions
(Sambrook and Russell 2001). OD600 nm measurements of
the fermentation tubes were carried out manually at 2-h inter-
vals. OD values of the negative control samples (no carbohy-
drate added) were deducted while measuring their correspond-
ing samples and positive controls.
Enzyme incubations
The GL34 mixture (1 mg mL−1) was incubated for 24 h with
different carbohydrate degrading enzymes (5 U mL−1): α-
amylase 1 (porcine pancreas); α-amylase 2 (Aspergillus
oryzae); α-glucosidase (yeast); Iso-amylase (Pseudomonas
sp.; pullulanase type 1 (Klebsiella planticola); β-galactosidase
1 (A. oryzae) andβ-galactosidase 2 (Kluyveromyces lactis) (see
Table S1 with detailed information).
Intracellular and extracellular activity essays
After growth with GL34 as their only carbon source, the three
tested Bifidobacterium strains were harvested by centrifuga-
tion at 10,000×g for 15 min at room temperature. Culture
supernatants were sterilized using 0.45-μm filters and concen-
trated 10 times by Amicon Ultra-4 centrifugal filter units
(10,000-Da molecular weight cutoff, Millipore). The harvest-
ed cell pellets were washed twice with 0.1 M potassium phos-
phate buffer (pH 6.6) and then suspended in 1 mL of this
buffer into 2.0-mL screw-cap microtubes containing 400 mg
of 0.1-mm-diameter glass beads (Biospec Products). Cell dis-
ruptions were carried out by homogenization by a mini bead-
beater (Biospec Products) at 4200 rpm for six 1-min cycles
with 40-s cooling on ice in between. The cytoplasmic extracts
were harvested by centrifugation at 10,000×g for 5 min to
remove cell wall fragments, and then concentrated to one fifth
of the initial volume using Amicon Ultra-4 units as above.
The concentrated cell-free supernatants and cytoplasmic
extracts (10 μg protein for each) were incubated separately
with 5 mg mL−1 of the GL34 mixture. All reactions were
performed in Milli-Q at 37 °C for 24 h. The progress of the






















Scheme 1 Structures of
compounds F1–F5 from the
mixture GL34
Appl Microbiol Biotechnol (2019) 103:707–718 709
High-pH anion-exchange chromatography
Samples were analyzed on an ICS-3000 workstation (Dionex,
Amsterdam, the Netherlands) equipped with an ICS-3000 pulse
amperometric detection (PAD) system and a CarboPac PA-1
column (250 × 2 mm; Dionex). The analytical separation was
performed at a flow rate of 0.25 mL min−1 using a complex
gradient of eluents A (100 mMNaOH); B (600 mMNaOAc in
100 mM NaOH); C (Milli-Q water); and D 50 mM NaOAc.
The gradient started with 10% A, 85% C, and 5% D in 25 min
to 40% A, 10% C, and 50% D, followed by a 35-min gradient
to 75% A, 25% B, directly followed by 5-min washing with
100%B and reconditioning for 7 min with 10%A, 85% B, and
5%D. External standards of lactose, glucose, and fructose were
used for calibration. For the determination of glucosylated lac-
tose compounds with a degree of polymerization (DP) of 3,
maltotriose was used as external standard.
Bioinformatic analysis
All protein sequences from B. adolescentis ATCC 15703,
B. longum subsp. infantis ATCC 15697, B. breve DSM
20123, and B. breveUCC 2003 used in this study were extract-
ed from the National Center for Biotechnology Information
(NCBI) database. Database searches used the non-redundant
sequence database accessible at the NCBI website (http://
www.ncbi.nlm.nih.gov) using BLASTP and global align
search. The BLASTP searches and multiple-sequence align-
ments were used to find similarity between the characterized
glucosidases of B. breveUCC 2003 and annotated glucosidases
encoded by the studied bifidobacterial strains. Annotation of
carbohydrate-active enzymes encoded by the genome se-
quences of L. reuteri 121 and L. acidophilus ATCC 4356 was
carried out using dbCAN (http://csbl.bmb.uga.edu/dbCAN).
Results
Enzymatic hydrolysis of compounds in the GL34
mixture
The GL34 mixture of five compounds was synthesized using
glucansucrase Gtf180-ΔN, decorating lactose with one or two
glucose units from sucrose as donor substrate, also introduc-
ing different types of linkages (Pham et al. 2017). GL34 con-
tains three DP3 compounds and two DP4 compounds, i.e., F1
(4′-glc-lac): α-D-Glcp-(1→ 4)-β-D-Galp-(1→ 4)-D-Glcp;
F2 (2-glc-lac): α-D-Glcp-(1→ 2)-[β-D-Galp-(1→ 4)-]D-
Glcp; F3 (3′-glc-lac): α-D-Glcp-(1→ 3)-β-D-Galp-(1→ 4)-
D-Glcp; F4 (4 ′ ,2-glc-lac): α-D-Glcp-(1→ 4)-β-D-
Galp-(1→ 4)-[α-D-Glcp-(1→ 2)-]D-Glcp; and F5 (3′,2-glc-
lac): α-D-Glcp-(1→ 3)-β-D-Galp-(1→ 4)-[α-D-Glcp-(1→
2)-]D-Glcp (4). Four types of glycosidic linkages thus occur
in this mixture, namely α(1→ 2), α(1→ 3), α(1→ 4), and
β(1→ 4). Only the F2 2-glc-lac compound had been de-
scribed before (Díez-Municio et al. 2012). The GL34 mixture
also contains glucosyl residues linked α(1→ 3)/α(1→ 4) to
the galactosyl residue of the original lactose. In view of the
novel composition of this mixture of glucosylated-lactose
compounds, we tested their resistance or sensitivity to hydro-
lysis with several commercially available enzymes. Following
incubations with the porcine pancreas and A. oryzae α-
amylases (Table S1), the HPAEC profiles at times 0 and
24 h showed no degradation of the GL34 compounds
(Fig. 1). Also various malto-oligosaccharide acting enzymes
(α-glucosidase, iso-amylase and pullulanase, Table S1) were
tested for their ability to hydrolyze GL34 compounds.
However, after 24-h incubation, no (monomeric or dimeric)
products were detected in the reaction mixtures with these
three enzymes (Fig. 1). None of these α-glucose cleaving
enzymes thus was active on the GL34 compounds.
Subsequent incubation of the GL34 mixture with the β-
galactosidase enzymes from A. oryzae and K. lactis
(Table S1) however, did result in (some) hydrolysis. Fig. 1
shows that galactose and kojibiose (a glucose disaccharide with
α(1→ 2)-linkage) were released during incubation with β-ga-
lactosidase, especially with the A. oryzae enzyme. Only the
peak corresponding to F2 2-glc-lac disappeared, the only
GL34 compound with a terminal galactosyl residue. We subse-
quently studied the utilization of these GL34 compounds for
growth by (selected) common intestinal bacteria in more detail.
Growth of human gut bacteria on the GL34 mixture
Fermentation of GL34 compounds by probiotic Lactobacillus
strains
In this study, we tested L. casei W56, L. acidophilus ATCC
4356, and L. reuteri 121 and observed that all three strains
showed limited growth on media with the GL34 mixture as
the only carbon source (5 mgmL−1): the final (relative) OD600
values reached were 3.8%, 10.4%, and 26.5%, respectively,
compared to a 100% control grown on glucose (Fig. 2).
Fermentation of GL34 compounds by probiotic
Bifidobacterium strains
The GL34 mixture (5 mg mL−1) showed different stimulatory
effects on the growth of B. breveDSM 20123, B. adolescentis
ATCC 15703, and B. longum subsp. infantis ATCC 15697.
B. adolescentis grew very well on GL34, its final OD600 value
reached 80% of that of a 100% control growing on lactose, the
purified TS0903 GOS mixture, and the GOS/FOS mixture
(Table 1). However, the final OD600 values for growth of
B. breve DSM 20123 and B. longum subsp. infantis ATCC
15697 on GL34 remained below 50% of the values for growth
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on lactose, the purified TS0903 GOS mixture and the GOS/
FOS mixture (Table 1).
The tested bifidobacterial strains displayed two or more
growth phases (Fig. 3 and Fig. S1). Some compounds in the
GL34 mixture thus are more preferred growth substrates than
others. B. breve and B. longum subsp. infantis grew more slow-
ly on GL34 than B. adolescentis. They reached OD values
around 0.70 after 24 h incubation compared to 12 h for
B. adolescentis. Final maximal OD values were 0.86 for
B. breve and 0.73 for B. longum subsp. infantis and 1.60 for
B. adolescentis. The latter strain appeared to go through differ-
ent lag phases, adapting to the different carbon sources in
GL34, reaching maximal OD after 36 h of incubation (Fig. S1).
Fermentation of GL34 compounds by commensal gut
bacteria
Also, the ability of two selected commensal bacteria to grow
on the GL34 mixture was studied. B. thetaiotaomicron is a
Gram-negative anaerobic bacterium found dominantly in hu-
man distal intestinal microbiota (Xu et al. 2003). E. coliNissle
represents ecologically important inhabitants of the human
intestinal tract (Mason and Richardson 1981). Growth of
E. coli Nissle on the GL34 mixture, TS0903 GOS and a
GOS/FOS mixture (5 mg mL−1), was relatively minor with
final OD600 values of 0.19 ÷ 0.35 after 24-h of incubation,
compared to growth on lactose and glucose with final OD600
values of 0.66 and 0.74, respectively (Fig. 4, panel 1). The
final OD600 value of B. thetaiotaomicron was 0.53 after 72 h
of incubation, but its growth displayed a pronounced lag
phase (Fig. 4, panel 2). This strain thus may fail to compete
with other bacteria which have shorter lag phases of growth
with the GL34 mixture, such as the bifidobacteria tested and
E. coli Nissle.
We subsequently identified the specific GL34 compounds
utilized by these strains, and products derived, also aiming to
elucidate which hydrolytic enzyme activities are involved,
with emphasis on β-galactosidases and α-glucosidases.
Fig. 1 HPAEC profiles of
oligosaccharides in 1 = the GL34
mixture (1 mg mL−1, blank) and
the hydrolysis products after
incubation of GL34 with 2 = α-
amylase from porcine; 3 = α-
amylase from A. oryzae; 4 = α-
glucosidase from yeast; 5 = iso-
amylase fromPseudomonas sp.; 6
= pullulanase type 1 from
K. planticola; 7 = β-galactosidase
from A. oryzae and 8 = β-
galactosidase from K. lactis
Fig. 2 Growth of L. casei W56,
L. reuteri 121, and L. acidophilus
ATCC 4356 on GL34 compounds
(5 mg mL−1). Glucose
(5 mg mL−1) served as positive
control; growth studies were
carried out in triplicate
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Hydrolytic activity of commensal bacteria
and lactobacilli on the GL34 mixture
The GL34 compounds can be visualized as individual peaks
in HPAEC-PAD chromatograms. The compounds con-
sumed by the tested bacteria were validated by peak disap-
pearance at the corresponding retention time. HPAEC anal-
ysis of culture supernatants of the commensal bacteria
grown on the GL34 mixture showed that the F2 peak corre-
sponding to 2-glc-lac disappeared completely (Fig. 5), indi-
cating the selective and full utilization of only F2. Most
likely this is based on β-galactosidase degradation of F2
2-glc-lac, followed by α-glucosidase degradation of the
kojibiose formed, and finally, consumption of the galactose
and glucose formed for cellular growth. Only in the case of
E. coli Nissle degradation resulted in accumulation of
kojibiose. This was not investigated any further. Besides,
B. thetaiotaomicron was also able to degrade F4 4′,2-glc-
lac partially (Fig. 5).
HPAEC profiles of L. casei W56 culture supernatants
showed that none of the GL34 compounds were degraded
(Fig. 6), in line with the very limited growth observed
(Fig. 2). When searching the annotated genome sequence of
this strain in the CAZy database (http://www.cazy.org/
b7858.html), we did not find any (putative) β-galactosidase.
This most likely explains the inability of L. casei W56 to
hydrolyze the galactose β(1→ 4) linked to glucosyl residue
in F2 2-glc-lac. Many putative α-glucosidases were found
encoded in the genome sequence of this strain, however. In
view of the results obtained, these enzymes apparently are
inactive on the GL34 compounds, or the GL34 mixture is
unable to induce their expression. This was not investigated
further.
Lactobacillus acidophilus ATCC 4356 and L. reuteri 121
strains only showed hydrolytic activity with F2 2-glc-lac in
the GL34 mixture. L. reuteri 121 degraded this compound to a
higher level than L. acidophilus ATCC 4356 (Fig. 6).
Annotation of carbohydrate-active enzymes encoded by the
genome sequence of L. reuteri 121 (Gangoiti et al. 2017)
was carried out using dbCAN (http://csbl.bmb.uga.edu/
dbCAN). One putative β-galactosidase of family GH2 was
detected (gene number: BJI45_06415), which may be respon-
sible for hydrolysis of F2. β-Galactosidases of this GH2 fam-
ily are known to hydrolyze a wide variety ofβ-(1→ 2, 3, 4, or
6) GOS, including oligosaccharides with a degree of polymer-
ization of 3–6 (Gänzle 2012). Kojibiose released from the F2
compound by this strain remained in the medium without
being degraded (completely). Only a single (predicted) extra-
cellular α-glucosidase of family GH31 was encoded in the
genome of L. reuteri 121 (gene number: BIJ45_02455)
(Gangoiti et al. 2017). This enzyme is apparently unable to
effectively degrade kojibiose. Apparently, there is also no
transporter expressed that can facilitate the uptake of kojibiose
for intracellular degradation.
Lactobacillus acidophilus ATCC 4356 is known to encode
a β-galactosidase (LacZ, classified in the GH2 family)
(Gänzle 2012; Schwab et al. 2010; Pan et al. 2010).This
LacZ enzyme thus may be responsible for degradation of the
β(1→ 4)-linkage in F2 and release of kojibiose. Annotation
of carbohydrate-active enzymes encoded by the genome se-
quence of L. acidophilus ATCC 4356 (Palomino et al. 2015)
was also carried out by dbCAN (http://csbl.bmb.uga.edu/
dbCAN). Ten putative α-glucosidase enzymes (family
GH13 and GH31) were annotated in the L. acidophilus
ATCC 4356 genome. Agl3 is anα-glucosidase identified in
B. breve UCC 2003, with a broad hydrolytic activity towards
all possible α-glycosidic linkages, including the α(1→ 2)
linkage in sucrose and kojibiose (Kelly et al. 2016).
However, a BLAST analysis of these putative glucosidases
of L. acidophilus ATCC 4356 and Alg3 showed very low
similarity in protein sequence (between 24 and 31%)
(Table S2). The observed accumulation of kojibiose in the
growth medium of L. acidophilus ATCC 4356 (Fig. 6)
thus may be due to lack of an extracellular α-glucosidase
active on α(1→ 2) linkages. Furthermore, it is possible
that the α-glucosidase enzymes of this strain are only in-
tracellular enzymes and that a suitable transporter for
kojibiose is absent.
Table 1 Growth of B. adolescentis ATCC 15703, B. longum subsp. infantis ATCC 15697 and B. breve DSM 20123 on different carbon sources
(5 mg mL−1) for 36 h, and the final pH values
Carbon sources Bifidobacterium adolescentis ATCC
15703




OD600 % pH OD600 % pH OD600 % pH
Lactose 2.00 ± 0.00 100 5.0 2.00 ± 0.00 100 5.0 2.00 ± 0.00 100 5.0
GOS 2.00 ± 0.00 100 5.0 1.77 ± 0.02 89 5.2 1.64 ± 0.04 82 5.3
GOS/FOS 2.00 ± 0.00 100 4.9 1.79 ± 0.02 90 5.3 1.61 ± 0.01 81 5.2
GL34 1.60 ± 0.03 80 5.0 0.73 ± 0.03 37 5.3 0.86 ± 0.04 43 5.4
The experiments were carried out in triplicate, and the average values are shown
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Hydrolytic activity of the Bifidobacterium strains
on the GL34 mixture
Typically, bifidobacteria have extracellular endohydrolases
acting on glycosidic bonds of oligo- and polymeric substrates,
yielding smaller products which are internalized by
carbohydrate-specific (ABC type) transporters. Further utili-
zation may be carried out by cytoplasmic GHs such as α/β-
glucosidases and α/β-galactosidases to produce monosaccha-
rides which are used for growth (O’Connell-Motherway et al.
2011; O’Connell et al. 2013). To try and identify the
bifidobacterial enzymes responsible for utilization of GL34
compounds, cells grown in modified BM broth containing
5 mg mL−1 GL34 were harvested at 36 h (Fig. 3). Three
fractions were prepared, namely growth culture supernatants,
concentrated culture supernatants and cytoplasmic extracts
(see BMaterials and methods^). GL34 was incubated with
concentrated culture supernatants and cytoplasmic extracts
to verify the presence or absence of extra- and/or intracellular
enzyme activities involved in degradation.
Bifidobacterium adolescentis ATCC 15703
Bifidobacterium adolescentis was able to utilize all GL34
compounds, and only 10 and 60% of F4 4′,2-glc-lac and F5
3′,2-glc-lac remained, respectively (Fig. 7, panel 1). This also
Fig. 3 Growth of B. adolescentis ATCC 15703, B. longum subsp. infantis ATCC 15697, B. breve DSM 20123, E. coli Nissle, B. thetaiotaomicron in
medium supplemented with 5 mg mL−1 GL34 at different times of incubation (h). Growth experiments were carried out in triplicate
Fig. 4 1 Growth of E. coli Nissle
on the GL34, TS0903 GOS, and
GOS/FOS mixtures (5 mg mL−1);
lactose and glucose (5 mg mL−1)
served as positive controls. 2
Growth of B. thetaiotaomicron on
the GL34 compounds
(5 mgmL−1); lactose (5 mgmL−1)
served as positive control. Growth
studies were carried out in
triplicate
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explains the relatively strong growth of this strain (Fig. 3).
None of the GL34 compounds were hydrolyzed by cell-free
culture supernatants of this strain. Its cell extracts only hydro-
lyzed F1 4′-glc-lac, F2 2-glc-lac, and F4 4′,2-glc-lac com-
pounds (Fig. 7, panel 1). Three α-glucosidases are annotated
in the B. adolescentis ATCC 15703 genome sequence (http://
www.cazy.org), namely AglB; AglA and BAD-0971. AglB
exhibited a preference for hydrolyzing α(1→ 4) linkages in
maltose (van den Broek et al. 2003), and most likely also is
involved in cleavage of the α(1→ 4) linkages present in the
F1 and F4 compounds. AglA showed high hydrolytic activity
only towards α(1→ 6) linkages in isomaltotriose and minor
activity towards α(1→ 1) linkages in trehalose (van den
Broek et al. 2003). None of these two enzymes are able to
degrade α(1→ 3) linkages occurring in F3 3′-glc-lac and F5
3′,2-glc-lac. It thus remained possible that during growth the
F3 and F5 were (partially) degraded by the BAD-0971 en-
zyme, the third B. adolescentis ATCC 15703 α-glucosidase.
The BAD-0971 protein has been annotated as an α-1,4-
glucosidase but has not been characterized yet (Suzuki et al.
2006). A BLASTP analysis was carried out to compare its
protein sequence with those of the characterized glucosidases
of B. adolescentis ATCC 15703 (AglA and AglB) and
B. breve UCC 2003 (Agl1; Agl2 and Agl3). Agl3 from
B. breve UCC 2003, as mentioned above, has a broad hydro-
lytic specificity towards α(1→ 2), α(1→ 3), α(1→ 4),
α(1→ 5), and α(1→ 6) in kojibiose, turanose, maltose,
leucrose, and palatinose, respectively (McLaughlin et al.
2015). The two other α-glucosidases of this strain (Agl1 and
Agl2) are more active in cleaving α(1→ 6) linkages (in
panose, isomaltose, isomaltotriose, and palatinose) and less
efficient in cleaving α(1→ 3) linkages in turanose and
nigerose, α(1→ 4) in maltulose and α(1↔2) in sucrose
(Pokusaeva et al. 2009). AglA and Agl3 exhibit 59% and
73% similarity/identity, respectively, to the BAD-0971 protein
of B. adolescentis (Table S3). The BAD-0971 enzyme may
have a broad hydrolytic specificity similar to Agl3. However
F3 3′-glc-lac and F5 3′,2-glc-lac with α(1→ 3) linkages
remained undigested in cell extracts. It cannot be excluded
that the cell disruption process has weakened activity of
BAD-0971 (annotated as an α-1,4-glucosidase), or other hith-
erto unidentified α-glucosidase enzymes.
Fig. 6 HPAEC profiles of
oligosaccharides in 1 = the GL34
mixture (1 mg mL−1, blank) and
the hydrolysis products of GL34
fermentation after 16 h of
incubation with 2 = L. caseiW56;
3 = L. acidophilus ATCC 4356; 4
= L. reuteri 121, and 5 = MRS
medium (blank)
Fig. 5 HPAEC profiles of
oligosaccharides in 1 = the GL34
mixture (1 mgmL−1, blank) and 2
= the hydrolysis products of
GL34 fermentation by a E. coli
Nissle at 40 hand b
B. thetaiotaomicron at 72 h
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Bifidobacterium longum subsp. infantis ATCC 15697
The F2 2-glc-lac and F3 3′-glc-lac compounds were completely
utilized during growth of B. longum subsp. infantis, and the F1
4′-glc-lac, F4 4′,2-glc-lac and F5 3′,2-glc-lac compounds only
for 20–40% (Fig. 7, panel 2). Cell extracts only hydrolyzed F2
2-glc-lac, apparently involving (an) intracellular enzyme(s)
(Fig. 7, panel 2). The F1 4′-glc-lac, F3 3′-glc-lac, F4 4′,2-glc-
lacand F5 3′,2-glc-lac structures were not utilized by cell ex-
tracts of this strain, suggesting that it lacks α-glucosidase en-
zymes acting on glucose α(1→ 3)/α(1→ 4) linked to galacto-
syl residue. The complete use of the F3 3′-glc-lac compound
during growth of B. longum subsp. infantis ATCC 15697 thus
remained unexplained again. No extracellular activity of
B. longum subsp. infantis towards the GL34 mixture was de-
tected (Fig. 7, panel 2). Its limited activity on the GL34 mixture
resulted in the lowest growth extent (37%) compared to the
other two bifidobacteria (Table 1). Various glucosidases have
been annotated in the genome of B. longum subsp. infantis
mainly with activity onα(1→ 4) andα(1→ 6) glucosidic link-
ages, namelyα-1,4 glucosidase (locus tag BLIJ-0129); putative
amylase (locus tag BLIJ-0286); putative iso-amylase (locus tag
BLIJ-0286 and BLIJ-2315); and oligo-1,6-glucosidase (locus
tag BLIJ-2526) (www.cazy.org/). However, BLAST analysis
showed very low similarity in their protein sequence between
the annotated glucosidases from this strain andAlg3 (Table S4).
This most likely explains the poor growth of this strain on the
GL34 mixture, and its limited intracellular activity on α1→ 3/
α1→ 4 glucosidic linkages in F1 4′-glc-lac, F3 3′-glc-lac, F4
4′,2-glc-lac, and F5 3′,2-glc-lac.
Bifidobacterium breve DSM 20213
In case of B. breve, four of the five GL34 compounds (F1 4′-
glc-lac, F3 3′-glc-lac, F4 4′,2-glc-lac, and F5 3′,2-glc-lac)
(partly) remained unutilized in culture supernatants after
growth (Fig. 7, panel 3). Amongst the three bifidobacteria
tested, only B. breve possessed extracellular activity on the
mixture GL34: the F2 2-glc-lac and F5 3′,2-glc-lac com-
pounds were completely degraded by cell-free supernatants
after 24-h incubation (Fig. 7, panel 3). The extracellular activ-
ity was also observed previously in different B. breve strains;
however, on α(1→ 4) and α(1→ 6) glucosidic linkages pres-
ent in starch, amylopectin and pullulan (Ryan et al. 2006).
Nevertheless, cell extracts fully hydrolyzed F2 2-glc-lac, F3
3′-glc-lac, and F5 3′,2-glc-lac (Fig. 7, panel 3). Most likely
B. breve is unable to transport F3 3′-glc-lac and F5 3′,2-glc-lac
into the cell. These data suggest that intracellular enzymes of
this strain were able to cleave off the glucose units α(1→ 3)
linked to the galactosyl residues occurring in F3 3′-glc-lac and
F5 3′,2-glc-lac but not the glucose unitsα(1→ 4) linked to the
galactosyl residues in F1 4′-glc-lac and F4 4′,2-glc-lac.
The putative α-glucosidases in the B. breve DSM 20213
genome, however, are annotated to act mainly on α(1→ 4)
and α(1→ 6) glucosidic linkages; namely α-1,4 glucosidase
(locus tag BBBR-0095); putative amylase (locus tags BBBR-
0101; BBBR-0825 and BBBR-0257) and oligo-1,6-glucosidase
(locus tags BBBR-0484 and BBBR-1863) (www.cazy.org/).
This uncharacterized α-1,4 glucosidase (locus tag BBBR-
0095) was found to have 99% similarity with Alg3 of B. breve
UCC 2003 (Table S4). This annotated α-1,4 glucosidase thus
also may be able to hydrolyze α(1→ 3) linkage in F3 3′-glc-lac
and F5 3′,2-glc-lac. Structures of F1 4′-glc-lac and F4 4′,2-glc-
lac may be inaccessible to this α-glucosidase, or it is unable to
cleave their α(1→ 4) linkages, thus explaining their (very) lim-
ited degradation by B. breve DSM 20213.
The annotated β-galactosidases (family GH2) of these
three Bifidobacterium strains are active on the F2 2-glc-lac
compound, containing a galactosyl-moiety with a β(1→ 4)
linkage to kojibiose. Following growth on GL34 as only car-
bon source, all three strains exhibited clear intracellular activ-
ity with F2 2-glc-lac. The data showed that individual
Fig. 7 Consumption of GL34 compounds (%) during growth of 1
B. adolescentis ATCC 15703; 2 B. longum subsp. infantis ATCC
15697; and 3 B. breve DSM 20213, and after 24-h incubations of
5 mg mL−1 GL34 with cytoplasmic extracts or cell-free supernatants
(obtained after growth of these three strains on the GL34 mixture)
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Bifidobacterium strains have preference for degradation of
glucosylated lactose compounds with α(1→ 3) and α(1→
4) glucosidic linkages.
Discussion
The GL34 compounds generally consist of a lactose molecule
at the reducing end that is elongated with one or more glucose
molecules involving different linkage types (Pham et al. 2017).
This combination of different monomers, i.e., glucose and ga-
lactose, with various linkage types (α(1→ 2), α(1→ 3),
α(1→ 4), and β(1→ 4)) and different degrees of polymeriza-
tion, increases the diversity of lactose-derived oligosaccharides
available. The GL34 compounds were resistant to degradation
by theα-amylases of porcine pancreas and A. oryzae. These are
endo-acting enzymes (EC 3.2.1.1), degrading α(1→ 4) gluco-
sidic linkages in polysaccharides such as starch or glycogen
(van der Maarel et al. 2002), mainly yielding glucose and malt-
ose. Also, various MOS-acting enzymes were tested: The α-
glucosidase enzyme of yeast used is known as an exo-acting
enzyme, hydrolyzing α(1→ 4) glucosidic linkages but only at
the terminal non-reducing (1→ 4)-linkedα-glucose residues of
di- and oligosaccharides to release a single glucose unit (Reese
et al. 1968). Iso-amylase from Pseudomonas sp. is an α(1→
4,6) debranching enzyme (van der Maarel et al. 2002).
Pullulanase type I of K. planticola hydrolyzes α(1→ 6) gluco-
sidic linkages in pullulan and starch (Domań-Pytka and
Bardowski 2004). Also, these three enzymes failed to cleave
any compounds in the GL34 mixture. Incubations with β-
galactosidase enzymes however did result in hydrolysis, but
only the F2 2-glc-lac molecule disappeared. This is explained
by the ability of these enzymes to catalyze hydrolysis of β-
glycosidic bonds between galactose and its organic moiety.
The combined data thus shows that the GL34 compounds are
(largely) resistant to hydrolysis by these common carbohydrate
degrading enzymes (Fig. 1).
There is abundant clinical evidence for the important roles of
Bifidobacterium and Lactobacillus species in the eco-
physiology of the intestinal microbiota (Picard et al. 2005;
Sanders and Klaenhammer 2001), and different strains of
lactobacilli are marketed as commercial probiotics. Individual
bifidobacteria are known to have specific substrate preferences
(Degnan and Macfarlane 1991). The GL34 mixture stimulated
growth of bifidobacteria, but indeed to different extents. Only
utilization of the F2 2-glc-lac compound has been studied pre-
viously and was shown to have a limited stimulatory effect on
the growth of B. breve 26M2. This F2 compound did not stim-
ulate growth of lactobacilli tested in our present study, as pre-
viously shown for L. casei LC-01 (García-Cayuela et al. 2014).
However, we observed that F2 2-glc-lac stimulated growth of
the probiotic bacteria L. reuteri 121, B. adolescentis ATCC
15703, B. longum subsp. infantis ATCC 15697, and B. breve
DSM20213, and also of two commensal bacteria,E. coliNissle
and B. thetaiotaomicron, albeit to various extents. This F2 com-
pound thus is less selective in comparison with the other com-
pounds in the GL34 mixture. Both F1 4′-glc-lac and F4 4′,2-
glc-lac also stimulated growth of all three tested bifidobacteria,
again to various extents. The presence of an α(1→ 3) linkage
makes F3 3′-glc-lac more selective than F1 and F4: F3 was
utilized by only two out of three studied Bifidobacterium
strains: B. adolescentis ATCC 15703 and B. breve DSM
20213. Also, F5 3′,2-glc-lac with both α(1→ 2) and α(1→
3) glucosidic linkages showed similar stimulatory effects on all
three Bifidobacterium strains.
In conclusion, the GL34 mixture promotes growth of the
tested bacteria to different extents. The bifidobacteria tested
generally were better at degrading GL34 compounds than
the lactobacilli and commensal bacteria. The stronger met-
abolic toolset of bifidobacteria in comparison with
lactobacilli also has been observed when comparing their
growth on human milk oligosaccharides and other prebiotic
oligosaccharides as primary carbon source (Watson et al.
2013; Sela et al. 2008; González et al. 2008; McLaughlin
et al. 2015). TheGL34mixture thus showed potential to shift
microbiota composition by specifically stimulating growth
of bifidobacteria, particularly B. adolescentis. Four out of
five compounds in this GL34 mixture exerted high and se-
lective growth stimulatory effects towards health-beneficial
probiotic bifidobacteria. The combination of monomer
composition and linkage type clearly determines the fer-
mentable properties of the GL34 compounds. Individual
gut bacteria were able to utilize only specific compounds
in the GL34 mixture. Synergistic activities between bacteri-
al species thus are likely to be essential for the utilization of
the whole GL34 mixture. In future work, this will be studied
in more detail, e.g., by using fecal bacterial cultures. Only
B. adolescentiswas able to utilize almost all structures, pro-
viding a potential synbiotic combination.
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